TET1 reprograms the epithelial ovarian cancer epigenome and reveals casein kinase 2α as a therapeutic target-Reference-Cited by-同舟云学术

TET1 reprograms the epithelial ovarian cancer epigenome and reveals casein kinase 2α as a therapeutic target

Published:2019-04-23 Issue: Volume: Page:
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Chen Lin‐Yu¹^ORCID,Huang Rui‐Lan²^ORCID,Chan Michael WY³⁴,Yan Pearlly S⁵,Huang Tien‐Shuo²,Wu Ren‐Chin⁶,Suryo Rahmanto Yohan⁷^ORCID,Su Po‐Hsuan²^ORCID,Weng Yu‐Chun²,Chou Jian‐Liang³,Chao Tai‐Kuang⁸,Wang Yu‐Chi⁹,Shih Ie‐Ming⁷¹⁰^ORCID,Lai Hung‐Cheng¹²¹¹

Affiliation:

1. Graduate Institute of Life SciencesNational Defense Medical Center Taipei Taiwan

2. Department of Obstetrics and GynecologyShuang Ho Hospital, Taipei Medical University New Taipei City Taiwan

3. Department of Biomedical SciencesNational Chung Cheng University Chiayi Taiwan

4. Institute of Molecular BiologyNational Chung Cheng University Chiayi Taiwan

5. Department of Molecular Virology, Immunology, and Medical Genetics, Comprehensive Cancer CenterThe Ohio State University Columbus OH USA

6. Department of PathologyChang Gung Memorial Hospital and Chang Gung University College of Medicine Taoyuan Taiwan

7. Department of PathologySidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medical Institutions Baltimore MD USA

8. Department of PathologyTri‐Service General Hospital, National Defense Medical Center Taipei Taiwan

9. Obstetrics and GynecologyTri‐Service General Hospital, National Defense Medical Center Taipei Taiwan

10. Department of Gynecology and ObstetricsJohns Hopkins Medical Institutions Baltimore MD USA

11. Department of Obstetrics and Gynecology, School of Medicine, College of MedicineTaipei Medical University Taipei Taiwan

Funder

National Health Research Institutes

Ministry of Science and Technology, Taiwan

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/path.5266

Reference63 articles.

1. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis;Shih Ie M;Am J Pathol,2004

2. The dualistic model of ovarian carcinogenesis: revisited, revised, and expanded;Kurman RJ;Am J Pathol,2016

3. Mutations in BRAF and KRAS characterize the development of low‐grade ovarian serous carcinoma;Singer G;J Natl Cancer Inst,2003

4. The molecular hallmarks of epigenetic control;Allis CD;Nat Rev Genet,2016

5. Epigenetic regulation of cancer‐associated genes in ovarian cancer;Kwon MJ;Int J Mol Sci,2011

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ring Finger Protein 217 Inhibits Ovarian Cancer Progression by Down‐Regulating HAX1 Expression;Advanced Therapeutics;2024-07-31

2. Active DNA Demethylase, TET1, Increases Oxidative Phosphorylation and Sensitizes Ovarian Cancer Stem Cells to Mitochondrial Complex I Inhibitor;Antioxidants;2024-06-17

3. TET1 is a Diagnostic and Prognostic Biomarker Associated with Immune Infiltration in Papillary Thyroid Cancer;Biochemical Genetics;2023-07-06

4. Ovarian cancer subtypes based on the regulatory genes of RNA modifications: Novel prediction model of prognosis;Frontiers in Endocrinology;2022-12-05

5. Protein kinase CK2 – diverse roles in cancer cell biology and therapeutic promise;Molecular and Cellular Biochemistry;2022-09-17